The Real Problem With Corporate Jets

<a href="http://flickr.com/photos/global-jet/2792358537/sizes/m/in/photostream/">Global Jet</a>/Flickr


Last year, executives for Mylan, the Pittsburgh-based generic drug maker, took the company’s two corporate jets on hundreds of flights to vacation hotspots such as Las Vegas, Miami, and the California wine country. The worst offender was CEO Bob Coury, who racked up $535,590 in personal jet flights on the company dime. Of course, Coury’s air travel perk pales in comparison to his overall pay package of $23 million, which included a big raise pegged to a 15 percent bump in the company’s share price. As long as Mylan rakes in profits, should shareholders care that its execs expense a few fun-filled weekend getaways?

The short answer is yes, according to a new report from GorvernanceMetrics International, a corporate oversight consultancy. Lavish spending on corporate jets rarely theatens to break a company on its own, but “if you’re looking for a red flag to provoke a wider look at a company’s governance and accounting practices, unusually high corporate jet perks is usually a pretty good one,” the report says. Among the Fortune 500 companies that doled out CEO jet perks last year, the top 10 percent of spenders, or 18 companies, all ranked worse than average on one or more measures of shareholder risk or excessive corporate pay.

Mylan, which also makes the EpiPen cure for severe allergic reactions, earned a “very high concern” rating from the Corporate Library executive pay consultancy and an “agressive” rating from Audit Integrity, which flags risks such as SEC violations. Mylan spent six times more on personal flights for its CEO than did larger drugmakers such as Johnson & Johnson and Pfizer. Only two other companies, Abercrombie & Fitch and the Wynn Resorts, shelled out more than Mylan on corporate jets last year.

“If a board can’t say “no” to a CEO’s request that the company pay for his or her vacation, or taxes, or tax advice (to list just a few examples), that board may not be exercising very strong oversight of CEO performance,” the report concludes. In other words, corporate directors who can’t keep their execs out of the honey pot are liable to get stung. And in Mylan’s case, an EpiPen probably won’t save them.

Corporate compensation and shareholder risk ratings for the biggest spenders on corporate jet perks:

Source: GovernanceMetrics InternationalSource: GovernanceMetrics International

 

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

Share your feedback: We’re planning to launch a new version of the comments section. Help us test it.